OpGen Announces Date of Third Quarter 2019 Financial Results Conference Call
October 29 2019 - 3:05PM
OpGen, Inc. (NASDAQ: OPGN) announced today that the Company will
report its third quarter 2019 financial results after the close of
the U.S. financial markets on Wednesday, November 6, 2019. OpGen’s
management team will host a live conference call and audio webcast
at 4:30 p.m. Eastern Time to discuss the Company’s financial
results and provide an update on business activities.
Dial-in InformationU.S. Dial-in Number: (844)
420-8185International Dial-in Number: +1 (216) 562-0481Webcast:
https://edge.media-server.com/mmc/p/p64ma2dvConference ID:
2899666
Replay DetailsU.S. Dial-in Number: (855)
859-2056International Dial-in Number: +1 (404) 537-3406Conference
ID: 2899666
Following the conclusion of the conference call, a replay will
be available through November 13, 2019. The live, listen-only
webcast of the conference call may also be accessed by visiting the
Investors section of the Company’s website at ir.opgen.com. A
replay of the webcast will be available following the conclusion of
the call and will be archived on the Company’s website for 90
days.
About OpGen
OpGen, Inc. is a precision medicine company harnessing the power
of molecular diagnostics and informatics to help combat infectious
disease. We are developing molecular information products and
services for global healthcare settings, helping to guide
clinicians with more rapid and actionable information about life
threatening infections, improve patient outcomes, and decrease the
spread of infections caused by multidrug-resistant microorganisms,
or MDROs.
Our molecular diagnostics and informatics products, product
candidates and services combine our Acuitas molecular diagnostics
and Acuitas Lighthouse informatics platform for use with our
proprietary, curated MDRO knowledgebase. We are working to deliver
our products and services, some in development, to a global network
of customers and partners. The Acuitas AMR Gene Panel (RUO) is
intended for Research Use Only and is not for use in diagnostic
procedures. The Acuitas Lighthouse Software is not distributed
commercially for antibiotic resistance prediction and is not for
use in diagnostic procedures. For more information, please visit
www.opgen.com.
OpGen, Acuitas, and Acuitas Lighthouse are registered trademarks
of OpGen, Inc.
OpGen Contact:Michael FarmerVice President,
Marketing(240) 813-1284mfarmer@opgen.com
Press Contact:Matthew BretziusFischTank
Marketing and PRmatt@fischtankpr.com
Investor Contacts:Joe GreenEdison
Groupjgreen@edisongroup.com
OpGen (NASDAQ:OPGN)
Historical Stock Chart
From Sep 2024 to Oct 2024
OpGen (NASDAQ:OPGN)
Historical Stock Chart
From Oct 2023 to Oct 2024